MetLife Investment Management’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-15,993
| Closed | -$38.9K | – | 2889 |
|
|
2023
Q2 | $38.9K | Hold |
15,993
| – | – | ﹤0.01% | 2909 |
|
|
2023
Q1 | $92.1K | Hold |
15,993
| – | – | ﹤0.01% | 2585 |
|
|
2022
Q4 | $143K | Buy |
15,993
+3,276
| +26% | +$29.3K | ﹤0.01% | 2436 |
|
|
2022
Q3 | $181K | Hold |
12,717
| – | – | ﹤0.01% | 2362 |
|
|
2022
Q2 | $186K | Hold |
12,717
| – | – | ﹤0.01% | 2378 |
|
|
2022
Q1 | $254K | Buy |
12,717
+4,557
| +56% | +$91K | ﹤0.01% | 2207 |
|
|
2021
Q4 | $143K | Buy |
+8,160
| New | +$143K | ﹤0.01% | 2263 |
|